The Ras proteins play a central role in regulating cell growth and their mutation can lead to abnormal proliferation. To analyse the potential link betwen AP1 activity, encoded by members of the jun and fos gene families, and Ras-mediated cellular transformation, we have studied several NIH3T3 clones which overexpress the Ha-Ras or Ki-Ras oncogenes. These transformed ®broblasts accumulated higher levels of cJun, JunB, Fra1 and Fra2 proteins relative to their normal counterparts. They also displayed increased AP1 DNA binding activity which was predominantly composed of cJun and Fra1 containing dimers. Following serum stimulation of Ras clones, the elevated levels of cJun and Fra1 remained steady, while the induction of JunB and Fra2 was partially attenuated. Moreover, deregulated Ras signaling resulted in a complete loss of the serum inducibility of cFos and FosB. Ectopic co-expression of cJun and Fra1 in NIH3T3 ®broblasts led to a transformed phenotype, attenuation of cFos serum inducibility, increased AP1 activity and Cyclin D1 accumulation, all characteristics of oncogenic Ras expressing cells. These results demonstrate that cJun and Fra1 are crucial mediators of the Ras-transformation process.
Introduction
The precise mechanism by which speci®c oncoproteins cause malignant transformation of cells by transmitting signals for aberrant growth is not fully understood. Proto-oncogenes commonly participate in the regulation of normal cellular growth through signal transduction pathways which convert extracellular stimuli into a program of gene expression. Many of these genes are also activated during the G 0 to G 1 transition when quiescent cells are stimulated by mitogens to re-enter the cycle. The rapid induction of such genes, called`immediate early genes' is followed by the transcription of downstream target genes that are critical for the proliferative response of the cell. A number of these immediate early genes encode transcription factors, including Jun and Fos.
Ras proteins play a central role in signal transduction (Feig and Cooper, 1988; Mulcahy et al., 1985; Smith et al., 1989) . These proto-oncogenes, frequently mutated in human tumors, connect receptors as the cell membrane with a cytoplasmic cascade of protein kinases followed by downstream nuclear events including induction of transcription and DNA synthesis. The proteins (p21Ras) encoded by the ras genes (Harvey-ras/Ha-ras, Kirsten-ras/Ki-ras and N-ras) bind guanine nucleotides, possess an intrinsic GTPase activity and cycle between an active (GTP bound) form and an inactive (GDP bound) state (Barbacid, 1987) . Activated p21Ras proteins stimulate a cascade of cytoplasmic protein kinases including Raf, MEK, MAPK (Mitogen Activated Protein Kinase) which in turn culminates in the phosphorylation of nuclear transcription factors resulting in transcriptional activation of growth-mediating genes (Bollag and McCormick, 1991; Boulton et al., 1991; de Vries-Smit et al., 1992; Dent et al., 1992; DeÂ rijard et al., 1994; Hibi et al., 1993; Howe et al., 1992; Kyriakis et al., 1992; Lowenstein et al., 1992; Wood et al., 1992) .
The induction of c-jun and c-fos transcription is one of the earliest nuclear responses to a wide variety of extracellular stimuli and is thought to be crucial in mediating cellular proliferating (Curran and Franza, 1988; Herschman, 1991) . The mitogen stimulation of c-fos transcription is a paradigm for a gene regulated via the Ras pathway. The SRE (Serum Response Element) in the c-fos promoter is continuously bound by two nuclear proteins SRF and Elk/TCF (Herrera et al., 1989; KoÈ nig, 1991; Norman et al., 1988; Prywes and Roeder, 1987; SchroÈ ter et al., 1990; Shaw et al., 1989; Treisman, 1987) . Upon Ras activation Elk1 is rapidly phosphorylated by MAPK-1 and MAPK-2 (also called ERK1 and ERK2) resulting in a strong increase in its transcriptional activity (Hipskind et al., 1994; Prywes et al., 1988; Zinck et al., 1993) . A dierent mechanism has been proposed for c-jun transcriptional activation which involves a cJun/ ATF2 heterodimer stably bound to a TRE element in the c-jun promoter (van Dam et al., 1993) . Ras activation promotes phosphorylation of the cJun protein augmenting its transcriptional activity (BineÂ -truy et al., 1991; Smeal et al., 1991) .
The jun and fos families of genes are composed of three jun members (c-jun, junB, and junD) (Bohmann et al., 1987; Hirai et al., 1989; Maki et al., 1987; Ryder et al., , 1989 and four dierent fos partners (c-fos, fosB, fra1 and fra2) (Cohen and Curran, 1988; Nishina et al., 1990; Zerial et al., 1989) . These genes encode components of the AP1 transcription factor formed by homo-or hetero-dimerization of the Jun and Fos proteins. Dimerization occurs through a leucine-repeat located in the highly conserved C-terminal part of the Jun proteins or in an internal position in the Fos proteins (Landschulz et al., 1988; Sassone-Corsi et al., 1988a) . As the Fos proteins do not form dimers among themselves, AP1 is a set of low anity Jun/Jun and high anity Jun/Fos dimers (Nakabeppu et al., 1988) . This complex set of dimers recognizes and binds to the TRE element (TPA Responsive Element or TGACT-CA) through the basic domain of both proteins, adjacent to the Leucine-zipper. AP1 recognition sequences are found in many promoters and enhancers of cellular and viral genes, including Collagenase, Stromelysin, Metallothionein IIA, Interleukin 2, Transforming Growth Factor b, Simian Virus 40, Polyomavirus and Papillomavirus. The dierent AP1 dimers exhibit similar DNA binding speci®cities but dier in their transactivation eciencies Hirai et al., 1990; Suzuki et al., 1991) . The binding anities for dierent dimer combinations is dependent on the speci®c TRE sequence and on the promoter context (Halazonetis et al., 1988; Ryseck and Bravo, 1991) . Moreover, the jun and fos immediate early genes are dierentially expressed during development and in adult tissues (Dony and Gruss, 1987; Hirai et al., 1989; Wilkinson et al., 1989) . They also respond dierently to mitogenic stimuli, genotoxic or differentiating agents (Almendral et al., 1988; de Groot et al., 1990; Devary et al., 1991; Lau and Nathans, 1987;  Ras Protein Clone
v v Figure 1 Characterization of Ras expressing ®broblasts. Dierent neomycin-resistant clones were isolated after stable transfection of an activated Ha-ras gene in NIH3T3 ®broblasts. The level of Ras expression was analysed by immuno¯uorescence and immunoblot staining with a speci®c anti-Ras monoclonal antibody (see Material and methods). The plating eciency of soft agar clones was de®ned as the ratio of the number of macroscopic colonies after 15 days of growth to the number cells initially seeded.
The plotted numbers represent data of one typical experiment. There was a good correlation between the amount of activated Ras and transformation as measured by a soft agar assay (ie: normal NIH3T3 ®broblasts or clone R5 that did not show accumulation of Ras protein do not grow in agar, whereas clones expressing the higher levels of Ras produced the higher number of colonies) Mechta et al., 1989; Ryseck et al., 1988; Lallemand et al., 1997) . These observations suggest that, under various conditions, the members of the Jun and Fos families present dierent properties and have distinct functions. Several lines of evidence suggest that AP1 couples signals from activated Ras proteins to the transcription of target genes in transformed cells. Blocking AP1 activity using dominant negative cJun or cFos mutants reverts the transformed phenotype of Ras-overexpressed NIH3T3 ®broblasts (Lloyd et al., 1991; Suzuki et al., 1994) . A correlation was also observed between Ras transforming eciency and cJun transcriptional activity (Alani et al., 1991; Westwick et al., 1994) . This is consistent with the idea that AP1 complexes containing cJun are essential downstream eectors of Ras. In a recent study, we reported opposing eects of cJun or JunD overexpression on transformation by Ras (Pfarr et al., 1994) . While cJun cooperated with Ras, excess JunD partially reversed the transformed phenotype. These experiments suggested that dierent Jun and Fos proteins might modulate Ras signals dierently. Furthermore, it remained unknown which Fos proteins heterodimerize with cJun in these cells and which AP1 dimers may be necessary for transformation by Ras. Therefore, we set out to measure the level of the Jun and Fos proteins and the AP1 DNA binding activity in dierent Ras transformed cell lines and attempted to establish a relationship between AP1 composition and the transformed phenotype.
Results

Increased expression of cJun, JunB, Fra1 and Fra2 in Ras transformed cells
To study the consequences of oncogenic Ras expression on AP1 composition, we isolated a set of Rastransformed clones by transfection of NIH3T3 fibroblasts with an activated Ha-ras gene isolated from a human bladder carcinoma (Shih and Weinberg, 1982) together with a plasmid conferring neomycin resistance. Four clones R2, R3, R4 and R5 were selected and expanded for further analysis. In addition, a well characterized NIH3T3-derived cell line (DT) transformed by incorporation of two copies of a Ki-ras gene (Noda et al., 1983) was also used in this study and renamed for convenience R1. Ras expression, the transformed phenotype, and the Jun and Fos protein levels were monitored for each clone. The level of Ras expression was determined both by immuno¯uorescence and Western blotting and the extent of transformation was evaluated by scoring colony formation in agar. As shown in Figure 1 , the frequency of agar colony formation was roughly proportional to the level of Ras protein accumulation. In this experiment, we did not distinguish between the endogenous Ras and the overexpressed mutant Ras, but rather estimated the total level of Ras protein.
The levels of the Jun and Fos proteins were determined by Western blot analyses. A set of speci®c rabbit polyclonal antibodies with similar ranges of reactivity was used to determine the level of accumulation of the dierent Jun and Fos proteins (Pfarr et al., 1994; Lallemand et al., 1997) . As shown in Figure 2 , each of the three Jun proteins were detected in growing NIH3T3 cells, while Fra2 is the only Fos member detected in these cells. Transformation by Ras resulted in an increase in the levels of cJun and JunB proteins relative to the parental NIH3T3 cells. JunD expression was markedly lower in the more transformed clones (R2 and R1). Fra1 and Fra2 protein levels were increased in all of the transformed cell lines. Since Fra1 protein levels in normal NIH3T3 cells were lower than those of Fra2, the fold induction of Fra1 in the Ras clones was relatively higher. The R5 clone was an exception in that it expressed little if any exogenous Ras protein, did not grow in agar, yet still showed increased JunB, Fra1 and Fra2 expression. While transient expression of Ras oncoprotein results in increased levels of cFos and FosB (Stacey et al., 1987) , these proteins were not detected in our stable Ras transformed cells. cFos, FosB, and DFosB were each detected in serum-stimulated NIH3T3 ®broblasts which were used as a positive control ( Figure 3 ).
In the case of cJun we further analysed the events responsible for its overexpression. Northern blot analysis demonstrated that c-jun mRNA levels were increased roughly fourfold in the most transformed clones (R3, R2, R1) indicating heightened c-jun gene expression (due to c-jun transcription and/or c-jun mRNA stability) (data not shown). To determine the half-life of cJun protein in Ras-transformed fibroblasts, we performed pulse/chase experiments with [ 35 S]methionine. The stability of the cJun protein was estimated by measuring the incorporated label following immunoprecipitation of cJun from these extracts. The half-life of cJun protein was enhanced 2.3-fold between NIH3T3 (t 1/2 =1.4 h) and the R1 cell line (t 1/2 =3.3 h). A correlation between the eciency of Ras transformation and the half-life of cJun was observed, with higher stability of cJun occurring in the most severely transformed Ras clones (R1 and R2) (data not shown).
Ras transformation results in constitutive expression of cJun and Fra1 and a loss of serum-inducibility of cFos and FosB
Growth factors present in serum (e.g. PDGF and EGF) stimulate cell proliferation by binding to tyrosine kinase receptors which activate the Ras signalling pathway. This in turn activates the immediate early genes, a step thought to be essential for mitogenesis. It was therefore surprising that constitutively expressed oncogenic Ras did not promote the synthesis of either the c-fos or fosB immediately early genes. We therefore checked the response of Ras-transformed cells to high concentrations of serum.
As shown in Figure 3 , cFos, FosB, and DFosB protein synthesis was stimulated by serum treatment of normal NIH3T3 cells whereas they were largely refractory to such treatment in Ras-transformed clones (R3, R2, R1). JunB and Fra2 were stimulated by serum in both NIH3T3 and R3 clone. However, their serum-inducibility was decreased in the R2 and lost in the R1 clone. As previously reported, JunD underwent a rapid and partial degradation after serum stimulation of NIH3T3 cells. The levels of JunD in Ras-transformed ®broblasts were rather insensitive to serum-stimulation. Finally, and in contrast to the other AP1 members, cJun and Fra1 protein levels remained constitutively elevated after serum addition. The constitutive levels of cJun in Ras clones was comparable to the level of cJun detected in serumtreated NIH3T3 while Fra1 protein levels in Rasoverexpressing ®broblasts was markedly higher than in serum-stimulated 3T3 ®broblasts. 
Ras enhances AP1 activity
To examine whether the quantitative and qualitative variations of Jun and Fos protein levels induced by the mutant Ras proteins modi®ed AP1 activity, we measured the AP1 DNA binding activity in nuclear extracts by gel retardation assays (Garner and Revzin, 1981; Piette et al., 1988) P labeled doubled stranded oligonucleotide containing a consensus TRE (TPA Responsive Element) from the collagenase promoter was used as probe. Equal amounts of nuclear protein extracts were used for each cell line. The AP1 binding activity was quanti®ed by the 32 P labeled signals of the retarded bands with a phosphoimager system and the bar graph in the right of (a) represents the average value and standard deviation for three independent experiments. (b) The composition of AP1 proteins bound to DNA was probed by addition of speci®c puri®ed polyclonal antibodies. The anti-Jun and anti-Fos antibodies decrease AP1-DNA complex formation. The degree of inhibition of AP1 DNA binding activity was estimated by measuring with a phosphoimager the intensity of the residual complex after addition of each antibody in the binding mixture. The symbols used in this ®gure represents the degree of inhibition of binding: ± sign corresponds to 0 ± 5%, +/±:10 ± 20% ++: 20 ± 30%, +++: 30 ± 50% and ++++: 50 ± 60% of inhibition binding activity was measured with equal amounts of nuclear extracts obtained from normal NIH3T3, the neomycin control clone (R5), and each of the previously described Ras-transformed clones; R1, R2 and R3. Figure 4a shows that AP1 DNA binding activity was enhanced roughly four-to ®vefold in Ras transformed ®broblasts relative to NIH3T3 parental cells. This experiment also showed a correlation between Ras-transforming potential and enhanced AP1 activity, as the highest AP1 binding was detected in the most transformed clones (R1 and R2). The composition of AP1 DNA binding activity was probed by addition of speci®c Jun and Fos antibodies to the binding mixture (Figure 4b ). Polyclonal antibodies abolish the AP1-DNA complex formation. Addition of puri®ed antibodies directed against cJun and Fra1 strongly decreased AP1 binding activity in Rastransformed ®broblasts. Fra2 was the main Jun partner in NIH3T3 cells whereas Fra1 became the major active Fos component in Ras-transformed ®broblasts. Nevertheless, JunB and Fra2 proteins also participated in AP1 binding activity in Rastransformed ®broblasts though less abundantly than cJun and Fra1. Corroborating with increased DNA binding activity, we have also observed an increased AP1 transcriptional activity by transient transfection assay using a chimeric construct carrying three TRE sites upstream of a minimal tk promoter (data not shown).
cJun and Fra1 are key mediators in Ras transformation
To determine if high concentrations of AP1 heterodimers composed of cJun and Fra1 were sucient for transformation, we tested if overexpression of cJun and Fra1 could replace oncogenic Ras. We isolated a set of Fra1 overexpressing clones either from the parental NIH3T3 cells or from ®broblasts stably expressing cJun (C1 clone). The C1 clone was isolated previously from NIH3T3 cells (Pfarr et al., 1994) . Fra1-overexpressing cells were obtained by transfecting a plasmid carrying the mouse fra1 cDNA driven by the SRa promoter along with a hygromycin B selectable marker contained in the pcDEBD vector (Nakabeppu et al, 1993) . Following selection, individual clones were screened for overexpression of Fra1 protein by immunoblot (Figure 5a ). Two clones (F1 and F2) isolated from NIH3T3 and three clones (CF1, CF2, CF3) isolated from C1 ®broblasts expressed constitutively high levels of Fra1 protein and were used for further analysis. Using RT-PCR with one primer in the SV40 leader of the transfected plasmid and another in the Fra1 coding sequence, we con®rmed that the exogenous Fra1 gene was expressed in F and CF clones (data not shown). The Fra1 protein level was markedly higher in clone C1 than in normal NIH3T3 cells and Fra1 protein accumulation seemed to be facilitated in the CF clones compared to F1 and F2. This may result from both positive autoregulation of the endogenous Fra1 promoter by AP1 (Busslinger and Bergers, 1994) and stabilization of the Fra1 protein by the heterodimerization with cJun.
We tested the transformed characteristics of these clones and compared them to the properties of Ras- The dierent clones display various morphologies: cJun and Fra1 overexpression leads to a refractile phase contrast image, fuciform shape, and compact nuclei approaching the phenotype of Ras-transformed cells. All of these cell lines were also assayed for growth in soft agar. To the right of each phase contrast image is a micrograph of a representative colony of cells in soft agar. The same magni®cation was used for phase contrast images of cells and micrographs of colonies. 10 2 or 10 3 cells were plated in 5 cm dishes and the number of visible colonies were scored after 15 days in culture. This number de®nes the plating eciency (as described in Figure 1 ) for each clone and is indicated on the right cells and was used in this comparative study. The morphology of the clones and their ability to grow in soft agar and in low serum are documented in Figures  5b and 6 , respectively. Phase contrast images show the distinct morphologies presented by the various clones (Figure 5b ). Fibroblasts overexpressing cJun alone (C1) and Fra1 overexpressing cells (F1, F2) were smaller than NIH3T3. F1 and F2 clones also grew overlapping one another. Nevertheless, these clones remained well attached to the culture dishes, a phenotype shared with normal ®broblasts. By contrast, clones overexpressing both cJun and Fra1 (CF1, CF2, CF3) displayed enhanced transformed properties: they were much smaller than NIH3T3, presented a highly refractile phase-contrast image, and grew with increased cell overlap. They were similar to the Ras-transformed ®broblasts (R2) with fuciform shape and compact nuclei, two characteristics of loss of contact inhibition. Nevertheless, the CF clones were slightly¯atter than R2 cells and remained better attached to the culture dishes.
F1, F2 and C1 clones grew slowly in low serum and formed small colonies in soft agar. Fra1-overexpressing ®broblasts grew slower than the cJun clone in serum free medium and resulted in fewer and smaller colonies in agar. Overexpression of both cJun and Fra1 in 3T3 ®broblasts synergized in conferring an almost fully transformed phenotype, though still less ecient than mutated Ras. CF clones gave rise to less colonies in soft agar (19 to 32% of cells seeded) than Rastransformed ®broblasts (74%) and the size of the colonies was smaller (Figure 5b ). This observation suggests that anchorage-independent growth was slower in CF clones than in Ras-expressing fibroblasts. This hypothesis was con®rmed by following the growth rate of these clones in serum-free medium ( Figure 6 ). CF clones grew slower in serum-deprived medium than Ras-transformed ®broblasts but they still proliferated faster under these conditions than normal ®broblasts (NIH3T3), cJun (C1), or Fra1 (F1, F2) overexpressing clones.
cJun and Fra1 overexpression abolishes cFos induction and increases cyclin D1 levels
As shown above, deregulated expression of both cJun and Fra1 resulted in a transformed phenotype. As Ras transformation resulted in attenuation of cFos serum inducibility and enhanced AP1 DNA binding activity, we checked if the up-regulation of cJun and Fra1 can confer these two properties to the cells. The experiments presented in Figure 7a and b demonstrated that these two parameters (attenuation of cFos serum inducibility and enhanced AP1 DNA binding activity) were observed in cells overexpressing both cJun and Fra1 proteins (CF1, CF2 and CF3 clones). The constitutive expression of cJun or Fra1 alone (C1, F1, F2 clones) slightly in¯uences these two properties (results not shown) but less markedly than overexpression of both proteins. cFos protein synthesis was still inducible in response to serum in C1, F1, or F2 clones, though less strongly than in NIH3T3. AP1 DNA binding activity was also slightly enhanced in these cell lines. Nevertheless, only cooverexpression of both cJun and Fra1 led to complete repression of c-fos induction and a strong increase in AP1 activity. Finally, as in Ras-transformed ®broblasts, we observed also that Fra2 protein levels increased in CFs cells relative to NIH3T3 (data not shown). Increased levels of cJun and Fra1 will result also in enhanced transcriptional activation of AP1 target genes. Since cJun-Fra1 heterodimers are strong activators of a canonical TRE element (Suzuki et al., 1991; L Bakiri, personal communication) .
Enhanced AP1 activity in Ras-transformed fibroblasts could be responsible for increasing and maintaining the expression of proliferation promoting genes. Ras transformation results in an elevated level of Cyclin D1 protein (Filmus et al., 1994; Liu et al., 1995) . The human Cyclin D1 gene is known to be regulated by AP1 (Herber et al., 1994) suggesting that the accumulation of this important G 1 /S regulator might be correlated with the enhanced AP1 activity observed in our stable Ras clones. The AP1-mediated induction of Cyclin D1 expression by activated Ras is also consistent with data showing that cAMP (which blocks Ras signal transduction) inhibits Cyclin D1 synthesis (Sewing et al., 1993) in addition to serum-or TPA-induction of c-jun . We therefore checked whether overexpression of cJun and Fra1 would result in increased Cyclin-D1 protein levels. Immunoblot experiments using a speci®c antiCyclin-D1 antibody demonstrated that overexpression of both cJun and Fra1 led to Cyclin-D1 accumulation to a level comparable to that in the R2 clone ( Figure  7c ). These reults con®rm that accumulation of cJunand Fra1-containing AP1 dimers confer several properties of Ras-overexpressing cells and contribute to the transformed phenotype of the cells.
Discussion
Mitogenic signal transduction initiated by activation of growth factor receptors at the plasma membrane leads to conversion of Ras into its GTP bound active form followed by a cascade of kinase activation. This is followed rapidly by phosphorylation of transcription factors and induction of immediate early gene expression. One of the transcription factors that is rapidly induced during this transition is AP1, composed of members of the Jun and Fos families. In the present study, we investigated the long-term eects of constitutive stimulation of the Ras-signaling pathway on the accumulation of Jun and Fos proteins. Previous studies have focused on short term eects and analysis at the mRNA level.
We show that the members of the AP1 family are dierentially regulated by constitutive oncogenic Ras expression, suggesting that they are implicated in distinct ways in the Ras signal transduction pathway. Overexpression of the Ha-Ras oncoprotein in mouse 3T3 ®broblasts increased the levels of cJun, JunB, Fra1, and to a lesser extent Fra2 proteins. JunD, previously identi®ed as an antagonist of Ras transformation was found to decrease in most cases. Surprisingly, no trace of cFos or FosB proteins was found in these transformed cells. The jun and fos genes also responded dierently to serum stimulation of these cells. The inducibility of JunB and Fra2 genes is markedly attenuated or even abolished in Rastransformed ®broblasts whereas elevated cJun and Fra1 protein levels remain steady under these conditions. Finally, cFos and FosB are only partially or not inducible at all by such serum treatment.
Both c-jun and junB mRNA levels were shown previously to be induced by transient expression of Ras (Sistonen et al., 1989) . We con®rm that the accumulation of cJun in stable Ras-transformed ®broblasts results from an increase in c-jun mRNA level as well as from the stabilization of its translation product. Ras leads to phosphorylation of cJun at two sites in its transactivation domain which increases its transcriptional activation activity (BineÂ truy et al., 1991) . Elevated c-jun gene expression partially results from positive autoregulation via two AP1 binding sites present in its promoter, as the AP1 binding activity targeting these two sequences is enhanced in Ras transformed cells (data not shown). The enhanced phosphorylation of cJun may also increase its stability. By contrast with cJun, an AP1-independent mechanism of regulation has been described for junB gene induction by Ras. The enhanced junB expression in Ras-transformed cells is, at least partially, mediated by c-Ets1 and c-Ets2 transcription factors through several ETS-binding sites in the murine junB promoter (Coer et al., 1994) .
The synthesis of Fra1 also becomes constitutive in Ras transformed ®broblasts. Similar to c-jun, fra1 is known to be regulated by AP1 itself. Transcriptional activation of the fra1 gene by AP1 is mediated by regulatory sequences in the ®rst intron (Bergers et al., 1995) . Elevated levels of fra1 mRNA were observed in ®broblasts overexpressing cJun, FosB, or Fra1 itself, indicating that the fra1 gene is up-regulated by itself or by other members of the AP1 family (Busslinger and Bergers, 1994; Miao and Curran, 1994) . Consistent with this idea, we observed that the level of Fra1 protein is increased in a cJun-overexpressing clone (C1) ( Figure  5a ). Thus, in Ras transformed ®broblasts, the Fra1 accumulation may also result from an AP-1 mediated positive auto-regulation loop. Fra1 up-regulation might be one consequence of the enhanced levels of cJun, JunB and Fra2.
As stated above, we never detected cFos, FosB, or DFosB proteins in the established Ras-overexpressing clones. By contrast, microinjection of Ras oncoprotein into quiescent NIH3T3 induces transient c-fos expression (Stacey et al., 1987) . We cannot exclude the possibility that there is a transient c-fos induction in our Ras clones at the beginning of Ras expression, but cFos protein remains completely undetectable in the stable Ras transformed cells. These results suggest that c-fos induction is required for initiation but not for maintenance of transformation. Moreover, c-fos is refractory to serum stimulation in most transformed clones suggesting that c-fos regulation is altered in transformed cells. Down-regulation of c-fos does not result from deletion of the c-fos gene due to cellular clonal selection as c-fos expression can be weakly stimulated by treatment of Ras-transformed ®broblasts with a high combination of high serum and ultraviolet irradiation (unpublished observation). Serum induction of c-fos has already been shown to be markedly attenuated in cells transformed by v-src, v-sis, v-ras or v-raf (Yu et al., 1993) . The v-src-mediated repression of c-fos induction occurs at the transcriptional level suggesting that prolonged oncogenic Ras expression could also inhibit c-fos transcription. Expression of c-fos following growth factor treatment of normal ®broblasts is transient and is stringently turned o (Lin et al., 1988; SchoÈ nthal et al., 1988) . The mechanism of c-fos downregulation is complex and involves dierent transcription factors including the cFos product itself (Sassone-Corsi et al., 1988b; SchoÈ nthal et al., 1989) . This autorepression requires the C-terminal domain of cFos. Similar sequences which also contain repressing activity exist in the other Fos family proteins, particularly Fra1 (O®r et al., 1990; Wilson and Treisman, 1988) . The accumulation of Fra1 in Ras-transformed cells might be important for mediating c-fos repression. This hypothesis is consistent with the fact that the ectopic expression of cJun and Fra1 also blocks the serum-response of the cfos gene. cJun and Fra1 might play a direct role in the transcriptional silencing of c-fos, perhaps by inhibition of the serum responsive elements (SRE) in the c-fos promoter. Indeed, the binding activity to the c-fos SRE sequence was decreased in Ras-transformed mouse osteoblast cell lines (Nose et al., 1989) .
The attenuation of c-fos serum inducibility may also involve down-regulation of growth factor receptors. The expression of the b-chain of the PDGF receptor in mouse ®broblasts was shown to be repressed by the vras or v-src oncogenes (Vaziri and Faller, 1995) . The reduced number of cell surface PDGF receptors present in transformed ®broblasts may desensitize the cells to subsequent stimulation by PDGF.
One critical event in Ras-mediated transformation seems to be the constitutive activation of AP1 transcription factors (Wasylyk et al., 1988) . AP1 activity is enhanced by expression of cellular or viral transforming oncogenes (such as activated Ras, Src, PymT) but not by expression of immortalizing oncogenes (including SV40T, PyLT, myc). Moreover, our results show a correlation between Ras transformation eciency and AP1 activity. The requirement for strong AP1 activity in Ras-transformed ®broblasts has been demonstrated in previous studies. Expression of transdominant Jun or Fos mutants is capable of reverting transformed cells to a normal phenotype (Lloyd et al., 1991; Suzuki et al., 1994) . Overexpression of wild-type Fra1 protein in NIH3T3 ®broblasts is by itself weakly transforming, though it is a more potent transforming gene in Rat1A cells (Bergers et al., 1995) . Overexpression of cJun alone also leads to partial transformation of 3T3 ®broblasts. However, co-overexpression of both cJun and Fra1 strongly increases the severity of the transformed phenotype. These observations suggest that the intrinsic transforming capacity of cJun and Fra1 is crucial in the establishment of Ras-mediated carcinogenesis. The enhanced AP1 activity in Ras-transformed ®broblasts suggests a model for signal ampli®cation and conversion of transient early events into longer term eects on gene expression. Ras transformation enhances the Cyclin D1 protein level, one of the major G 1 /S transition control factors. A recent report suggests that increased expression of Cyclin D1 in Ras-transformants is responsible for the shortening of the G 1 phase of these cells (Liu et al., 1995) . Overexpression of Cyclin D1 in NIH3T3 has been shown to accelerate G 1 progression and to decrease serum requirement for growth (Quelle et al., 1993) . Our results suggest that transformation by Ras leads to accumulation of the cJun and Fra1 transcription factors and enhances AP1 activity which in turn results in increased Cyclin D1 protein level which may accelerate G 1 progression.
Materials and methods
Cell culture
NIH3T3 cells and Ras-derived clones were maintained in Dulbecco's Modi®ed Eagle's minimal essential Medium (DMEM) containing 7% Fetal Calf Serum (FCS) and antibiotics.
Preparation of stable cell lines
The Ha-ras cell lines were established from a plasmid (pEJ6.6) containing a genomic activated Ha-ras gene isolated from a human bladder carcinoma. An expression vector (pSV-neo r ) encoding a neomycin-resistance gene was used as a selection marker and was cotransfected with the pEJ6.6 plasmid in NIH3T3 cells in 1:10 proportion. Fra1-overexpressing cells were obtained by transfecting a plasmid carrying the mouse fral cDNA driven by the SRa promoter along with a hygromycin B selectable marker contained in the pcDEBD vector (Nakabeppu et al., 1993) . NIH3T3 cells or C1 clone (Pfarr et al., 1994) were seeded at a density of 5610 5 cells per 10 cm diameter culture dish in DMEM complemented with 7% FCS. After 24 h the cells were transfected using the calcium phosphate coprecipitation method (Wigler et al., 1977) . Two days post-transfection, the cells were trypsinized, diluted 10-or 20-fold and selected in 100 mg/ml of G418 (geneticin antibiotic from Gibco BRL) or 200 mg/ml of hygromycin B (Calbiochem). Individual resistant clones were subcloned after 1 week of selection.
Soft-agar assays
For assay of cell growth in soft agar, three dilutions of cells were analysed. 10 2 , 10 3 , 10 4 cells were plated in 5 cm culture dishes onto a 3 ml basal layer (0.3% agar in DMEM plus 7% FCS) (Difco) over a solidi®ed cushion of 0.6% agar. Individual macroscopic colonies were counted after 2 weeks of growth.
Immuno¯uorescence microscopy
The dierent clones were seeded at the same initial density onto 20 mm glass coverslips, previously coated with a poly-L-lysine solution (Sigma). Cells were grown on these treated coverslips in 7% FCS DMEM. All the following steps were performed at room temperature in phosphate buered saline solutions (PBS). Cells were ®xed in 0.5% paraformaldehyde for 20 min, permeabilized in 0.1% Triton X-100 for 5 min, rinsed twice and blocked for 30 min in 0.05% Tween 20. The coverslips were incubated 2 h with the primary antibody (mouse monoclonal pan-Ras antibody from Oncogene Science #OP40), in PBS plus 0.05% Tween, rinsed three times and incubated 1 h with the secondary antibody (Fluorescein-coupled anti-mouse IgG, Amersham). The coverslips were washed in PBS and distilled water, mounted with an antibleaching glycerol mix (Citi¯uor±AF1) and viewed on a Zeiss Axiphot epiuorescence microscope. Cells were photographed with identical exposure times on TMAX 400 ®lms (Kodak).
Cell extracts and immunoblot analysis
Whole cell extracts and Western blotting were performed as described in Pfarr et al. (1994) . The Jun and Fos speci®c antibodies were prepared as described in Pfarr et al. (1994; Lallemand, et al., 1997) . The cyclin D1 antibody was a kind gift of Jiri Bartek. The blots were incubated with a horseradish peroxidase-conjugated secondary antibody (1/ 8000 dilution) followed by detection with enhanced chemiluminescence (ECL detection system from Amersham) and exposed to autoradiography ®lms.
Nuclear extracts and gel retardation assays
All solutions used for preparation of cell extracts and electrophoretic mobility shift assays contained 5 mg/ml of each of the following protease inhibitors: Aprotinin, Pepstatin A, Leupeptin, Antipain, and Chymostatin (all from Sigma). Cultured cells were washed with cold PBS and rapidly harvested by centrifugation. Cell pellets were resuspended in HNB buer (approximately 200 ml for 10 7 cells): 0.5 M sucrose, 15 mM Tris, 60 mM KCl, 0.25 mM EDTA 0.125 mM EGTA, 0.5 mM Spermidine, 0.15 mM Spermine. One half volume of HNB plus 1% NP40 was added to the solution and the cell lysates were immediately cleared in a microcentrifuge at 6000 r.p.m. for 3 min. The pellets were resuspended in NEB1 solution: 10 mM HEPES (pH=8.0), 25% glycerol, 1.5 mM MgCl 2 , 0.25 mM EDTA and a volume of NEB2 (NEB1 plus 0.7 M NaCl) was added. The mixture ws agitated (on a roller system) for 30 min at 48C and centrifuged 30 min at 13 000 r.p.m. Protein concentration was determined by the method of Bradford (Bio-rad protein assay). Extracts of dierent cell samples were stored in aliquots at 7808C. Equivalent amounts (2.5 mg) of nuclear extracts of the dierent cell samples were preincubated with puri®ed antisera (2 ml) during 10 min at 48C in binding buer: 10 mM HEPES (pH=7), 100 mg/ml BSA, 17.5% glycerol, 2 mM DTT, 0.5 mM Spermidine, 2 mM MgCl 2 and 1 mg of poly(dI-dC).poly(dI-dC). Next, 0.5 ng of a double stranded 32 P-labelled AP1 binding site (from the collagenase promoter 5'-AGCTAGCTGACTCAGATGTCCT-3') was incubated for an additional 10 min at 48C. DNAprotein complexes were resolved on 6% native polyacrylamide gels (Protogel from National Diagnostic), ®xed in 10% Methanol+10% acetic acid for 10 min, dried and visusalized by autoradiography.
